Ford debuts its new "smart vehicle, smart world" at CES in Las Vegas. Alyssa Julya Smith met up with Sherif Marakby, Vice President of Autonomous Vehicles & EV at Ford, to discuss when the company will be hitting the road with its self-driving cars. Earlier this year Ford teamed up with Domino's to deliver pizza to Michigan customers in driverless cars. Marakby discusses what went into making that experiment a successful one. Everything from which side of the car the touchpad should be on, to whether or not to integrate voice. Plus, what is the future of smart cities and what are the challenges? Marakby says the biggest challenge in autonomous driving is parking. Most cities don't have enough curb accommodations for a fleet of self-driving cars to succeed. He said that Ford will be testing a fleet of self-driving cars in a new city, to be announced later this year.

Share:
More In Business
Poll: More Americans think companies benefit from legal immigration
A new poll finds U.S. adults are more likely than they were a year ago to think immigrants in the country legally benefit the economy. That comes as President Donald Trump's administration imposes new restrictions targeting legal pathways into the country. The Associated Press-NORC Center for Public Affairs Research survey finds Americans are more likely than they were in March 2024 to say it’s a “major benefit” that people who come to the U.S. legally contribute to the economy and help American companies get the expertise of skilled workers. At the same time, perceptions of illegal immigration haven’t shifted meaningfully. Americans still see fewer benefits from people who come to the U.S. illegally.
Tylenol maker rebounds a day after unfounded claims about its safety
Shares of Tylenol maker Kenvue are bouncing back sharply before the opening bell a day after President Donald Trump promoted unproven and in some cases discredited ties between Tylenol, vaccines and autism. Trump told pregnant women not to use the painkiller around a dozen times during the White House news conference Monday. The drugmaker tumbled 7.5%. Shares have regained most of those losses early Tuesday in premarket trading.
Load More